Public reporting burden for this collection of information is estimated to average 1 hour per response, including the time for reviewing instructions, searching existing data sources, gathering and maintaining the data needed, and completing and reviewing this collection of information. Send comments regarding this burden estimate or any other aspect of this collection of information, including suggestions for reducing this burden to Department of Defense, Washington Headquarters Services, Directorate for Information Operations and Reports (0704-0188), 1215 Jefferson Davis Highway, Suite 1204, Arlington, VA 22202-4302. Respondents should be aware that notwithstanding any other provision of law, no person shall be subject to any penalty for failing to comply with a collection of information if it does not display a currently valid OMB control number. PLEASE DO NOT RETURN YOUR FORM TO THE ABOVE ADDRESS.
REPORT DATE (DD-MM-YYYY)
2. REPORT TYPE 5e. TASK NUMBER 5f. WORK UNIT NUMBER
DATES COVERED (From -
To
PERFORMING ORGANIZATION NAME(S) AND ADDRESS(ES) 8. PERFORMING ORGANIZATION REPORT NUMBER

Thomas Jefferson University
Philadelphia, PA 19107-6799
SPONSORING I MONITORING AGENCY NAME(S) AND ADDRESS(ES) 10. SPONSORIMONITOR'S ACRONYM(S) U.S. Army Medical Research and Materiel Command
Fort Detrick, Maryland 21702-5012
INTRODUCTION:
Alteration of the Fragile Histidine Triad (FHIT) gene, encompassing the FRA3B fragile site at chromosome 3p14.2 (1), especially reduction or deletion of its expression, is involved in many solid tumors including breast cancer. It is reported that a complete loss or a significant reduction of Fhit expression was observed in 72% of breast carcinomas examined and a correlation between a decrease or an absence of Fhit protein expression and high proliferation and large tumor size of breast cancer was identified (2) . Little is known about the biochemical and biological function of the Fhit in breast cancer progression. DNA double strand break (DSB) that may occur spontaneously and can be induced by DNA damage reagents such as ionizing radiation (IR) is one of the frequent reasons for promoting breast tumor genesis and development. The purpose of this proposal is to test our hypothesis that the over-activated ATR pathway in irradiated Fhit/ cells promote the homologous recombination-repair (HRR) of DNA DSBs, resulting in more Fhi t / cells surviving with deletion or translocations at fragile sites (malignant feature).
BODY:
Two major pathways repairing DNA DSB exist in mammalian cells: non-homologous rejoining (NHEJ) and homologous recombination repair (HRR). By studying Fhit knockout cell lines obtained from Dr. Huebner's laboratory (3), we observed that Fhit/ cells are more resistant to IR-induced killing than Fhit+/+ cells. The radioresistant phenotype of Fhitl cells is associated with stronger S and G2 checkpoint response cells ( Fig. 1) regulated by an over-activated ATR/CHK1 pathway ( Fig. 2-4 ) (4). Also, we found that ATR and CHKI that protecting cells from IR-induced killing is linked to HRR but not NHEJ (5, 6) . In addition, we demonstrated that Fhit affecting cellular radiosensitivity is linked to HRR but independent of NHEJ (7). The results are briefly described in the following paragraphs.
MATERIALS AND METHODS
Cell lines, chemical treatment and irradiation. Fhit+/+ and Fhit/ epithelial cells from mouse kidney, generated as described earlier (3), were immortalized by tissue culture passaging. These cells were adapted to growth in DMEM supplemented with 10% ironsupplemented calf serum (Sigma-Aldrich Co. USA) at 37°C in an atmosphere of 5% CO 2 and 95% air. Caffeine (Sigma-Aldrich Co.), or UCN-01 (National Cancer Institute, USA) was added to the culture 30 min before the cells were exposed to X-rays (310 kV, 10 mA, 2-mm Al filter) and was kept in the culture until the cells were collected.
DNA synthesis. The S phase (S) checkpoint is detected by measuring DNA synthesis, which is similar to that described previously (8) . Briefly, lxl0 5 cells from a growing culture were seeded in 60-mm tissue culture dishes with 3 ml of medium containin 10 nCi of [1 4 C]-thymidine and allowed to grow for more than one doubling time. This [ 4C] pre-labeling provides an internal control for cell number by allowing normalization for total DNA content of samples.
Before irradiation, the cell cultures were changed with pre-warmed medium (washed off (' 4 C)-thymidine) containing either caffeine or UCN-01 for 30 min. Cells were exposed to X-rays (310 kV, 10 mA, 2-mm Al filter) at room temperature and returned to 37°C. The chemicals were kept in the culture until cells were harvested. ( 3 H)-thymidine at 0.5 laCi was added to the culture for 30 min at 3 h after IR and the cells were then collected. The rate of DNA synthesis for each sample was calculated as 3 H dpm/l 4 C dpm and is presented as a percentage of the control values obtained from sham-irradiated cells at the same time-point, as described previously (8) .
Flow cytometry assay. The G2 checkpoint is detected by flow cytometry measurement. As described previously (9) , Fhit cells were collected at required times and fixed in 70% ethanol. Cells were washed with PBS and stained with a solution containing 62 lag/ml RNase A, 40 jtg/ml propidium iodide and 0.1% Triton X-100 in phosphate-buffered saline at room temperature for 1 h. The distribution of cells in the cell cycle was measured in a flow cytometer (Coulter Epics Elite, USA).
Kinase activity and western blot. Nuclear extracts were prepared by using the NE-PERTM kit (PIERCE, USA) according to the manufacturer's instructions. The fractions of chromatin-bound extract were prepared as described previously (10) . Briefly, cells were collected and washed in cold phosphate-buffered saline. Proteins were then extracted with cold 0.1% Triton X-100 in CSK buffer (10 mM PIPES pH 6.8, 100 mM NaCI, 300 mM sucrose, 1 mM MgCl 2 , 1 mM EGTA, 1 mM dithiothreitol, 1 mM phenylmethylsulfony fluoride) for 20 min at 4 0 C. The chromatin-bound fraction was then pelleted by low-speed centrifugation at 3,000 rpm for 5 min at 4'C. The supernatant was named fraction 1. These pellets were then re-extracted by incubating in the same CSK buffer and were collected by centrifugation at 3,000 rpm for 10 min at 4°C. This supernatant was named fraction 2. The final pellet fraction (containing chromatin-bound proteins) was solubilized in radioimmunopreciptation assay (RIPA) buffer (150 mM NaCl, 40 mM MOPS, pH 7.2, 1 mM EDTA, 1% NP40, 1% Sodium deoxycholate, 0.1% SDS) and was named fraction 3. For ATR kinase assay, 500 plg of fraction 3 was then mixed with 2 ýig of ATR antibody (sc-I1887, Santa Cruz Biotechnology, Inc. USA) in the presence of 20 la of a 50% (v/v) protein G-Sepharose slurry (RepliGen, USA) in 500 1 a of Buffer A (0.5% NP-40, 1 mM Na 3 VO 4 , 5 mM NaF, 0.2 mM PMSF in PBS buffer). For CHK1 kinase assay, 250 lag of nuclear extract was then mixed with 1 ýtg of CHK1 antibody (sc-7898, Santa Cruz Biotechnology, Inc.) in the presence of 10 4A of a 50% (v/v) protein A-Sepharose slurry in 250 a1 of Buffer A. These mixtures were gently rotated overnight at 4VC. Immune complexes were washed twice with Buffer A, then twice with Buffer B (10 mM HEPES, pH 8.0, 50 mM NaCl, 10 mM MgCl 2 , 10 mM MnCI 2 , 1 mM DTT). The ATR kinase immunoprecipitate supplemented with I lag of PHAS-1 (Stratagene, USA) and the CHK1 kinase immunoprecipitate supplemented with I jtg of purified GST-CDC25C 200 . 256 (10) were incubated at 30 0 C for 30 min in 20 p.1 Buffer B containing 10 p.Ci (y-32P) ATP. Samples were analyzed by 12% SDS-PAGE and the kinase activities determined by measuring the incorporation of 32 p into PHAS-1 protein (ATR kinase) or into CDC25C 200 _ 25 6 (CHK1 kinase) with the Phospholmager. Antibodies against ATR (sc-1887, Santa Cruz Biotechnology, Inc. USA), CHK1 (sc-8404, Santa Cruz Biotechnology, Inc.) and CDC25A (sc-7389, Santa Cruz Biotechnology, Inc.) were used in the Western Blot.
Colony-forming assay. Cellular sensitivity to radiation was determined by the loss of colony-forming ability as described previously (9) .
Induction and rejoining of DNA double strand breaks (DSBs). Analysis of induction and rejoining of DNA DSBs is performed by using the asymmetric field inversion gel electrophoresis (AFIGE) assay as described before (5) . Briefly, cells in cold medium were irradiated and returned to the incubator at 37°C. At various times thereafter cells were collected and mixed with an equal volume of 1% agarose (InCert agarose, FMC). A similar protocol was also employed to determine induction of DNA DSBs except that in this case cells were embedded in agarose blocks prior to irradiation, and were placed in lysis buffer (10 mM Tris, pH 8.0, 50 mM NaCI, 0.5 M EDTA, 2% N-lauryl sarcosyl, 0.1 mg/ml proteinase E) immediately after irradiation. Blocks in lysis buffer were incubated first at 4°C for 45 min, and then at 50'C for 16-18 hrs. The blocks were washed in a buffer containing 10 mM Tris, pH 8.0 and 0.1 M EDTA, and treated at 37°C for 1 h with 0.1 mg/ml RNase A in the same buffer. AFIGE was carried out in 0.5% Seakem agarose (FMC) in 0.5X TBE (45mM Tris, pH 8. HRR Assay. The HRR assay was performed using the pDR-GFP system (obtained from Dr. Jasin's laboratory) (11) . Fhit wild type cells were transfected with pDR-GFP plasmid containing a mutated GFP gene with an 18 bp I-Scel site. The stably transfected cell lines were selected by growing in medium containing 5 itg/ml of puromycin. Puromycinresistant colonies were screened by Southern blots for intact DR-GFP reporter genomes. The positive cell lines were designated F-DRGFP. To evaluate HRR of DNA DSBs, F-DRGFP cells were either transfected with pGFP (containing full-length GFP cDNA) or transfected with pCMV3xnlsl-SceI plasmid (containing full-length I-Scel expression sequences, obtained from Dr. Nickoloff's laboratory (12)). Transient expression of I-Scel endonuclease generates a DSB at the integrated GFP gene sequences and stimulates HRR. GFP signal was assayed at two days post transfection by flow cytometry (Beckman Coulter, XL/MCL). Results were collected as dot plots of PMT1 (525 BP) to facilitate distinction between GFP positive and GFP negative cells. The frequency of recombination events was calculated from the frequency of GFP signal in F-DRGFP cells transfected with I-Scel by subtracting the frequency of GFP signal in F-DRGFP cells without transfection and dividing by the frequency of GFP signal in F-DRGFP cells transfected with pGFP.
Transfection of Atr, Chkl or Fhit siRNA. The Atr siRNA was designed to specifically target the sequences of the conserved region between rat and mouse Atr mRNA (5'-AAGACAGATTCTCTGCCAGTT-3'). The Chkl siRNA was designed to specifically target the sequences of the conserved region among human, rat and mouse Chkl mRNA (5'-AAGTTCAACTTGCTGTGAATA-3'). Fhit siRNA was designed to specifically target the sequences of the mouse Fhit mRNA (5'-AAGCAUUUCCAGGGGACCUCC-3'). The siRNAs were synthesized by Dharmacon, Inc. Scrambled duplex RNAs (Dharmacon, Inc. USA) were used in the control transfection. The RNAs were delivered to the cells by OLIGOFECTAMINETM (Invitrogen Corp. USA), according to the manufacturer's instructions. The cells were analyzed at 36 h posttransfection. were collected 6 h after IR (10 Gy). Protein Fhlt+I+ lnlt-/-levels were measured by using nuclear extracts from non-or irradiated Fhit cells.
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Methods. Thirty-six h after siRNA transfection, C the cells were exposed to X-rays (4 Gy) and • These findings provide an explanation for the relationship between Fhit expression and breast cancer progression. The importance of this research is that it will provide theory guidance for improving clinical treatment of breast cancers in which Fhit is deleted or reduced by combining traditional therapy with blocking the ATR/CHK1 pathway.
